Contemporary medicine is able to keep HIV in check: patients taking a carefully selected combination of drugs are prevented from developing AIDS. And yet the number of new infections continues to grow, with up to 40 million people living with HIV around the world. New research into pronucleotides, conducted at the PAS Institute of Bioorganic Chemistry, offers hope of potential new treatments.